相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy of Pharmacological Therapies for the Prevention of Fractures in Postmenopausal Women: A Network Meta-Analysis
Patricia Barrionuevo et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Comparison of Methods for Improving Fracture Risk Assessment in Diabetes: The Manitoba BMD Registry
William D. Leslie et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2018)
Significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients
M. Kamimura et al.
OSTEOPOROSIS INTERNATIONAL (2017)
Denosumab or Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates
P. D. Miller et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Effects of 18-month treatment with bazedoxifene on enzymatic immature and mature cross-links and non-enzymatic advanced glycation end products, mineralization, and trabecular microarchitecture of vertebra in ovariectomized monkeys
Mitsuru Saito et al.
BONE (2015)
Type 1 Diabetes Is Associated With an Increased Risk of Fracture Across the Life Span: A Population-Based Cohort Study Using The Health Improvement Network (THIN)
David R. Weber et al.
DIABETES CARE (2015)
Insights into bone fragility in diabetes: the crucial role of bone quality on skeletal strength [Review]
Masahiro Yamamoto
ENDOCRINE JOURNAL (2015)
Denosumab versus zoledronic acid in patients previously treated with zoledronic acid
A. D. Anastasilakis et al.
OSTEOPOROSIS INTERNATIONAL (2015)
Serum pentosidine levels after 3 years of bisphosphonate treatment in post-menopausal osteoporotic women
Hiroyuki Hashidate et al.
ENDOCRINE RESEARCH (2015)
Denosumab compared with risedronate in postmenopausal women suboptimally adherent to alendronate therapy: Efficacy and safety results from a randomized open-label study
C. Roux et al.
BONE (2014)
Contemporary Risk of Hip Fracture in Type 1 and Type 2 Diabetes: A National Registry Study From Scotland
Eleanor J. Hothersall et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2014)
Guidelines for the use of bone metabolic markers in the diagnosis and treatment of osteoporosis (2012 edition)
Yoshiki Nishizawa et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2013)
Denosumab Compared With Ibandronate in Postmenopausal Women Previously Treated With Bisphosphonate Therapy A Randomized Open-Label Trial
Chris Recknor et al.
OBSTETRICS AND GYNECOLOGY (2013)
Differences in non-enzymatic glycation and collagen cross-links between human cortical and cancellous bone
L. Karim et al.
OSTEOPOROSIS INTERNATIONAL (2013)
Type 2 Diabetes and Bone
William D. Leslie et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Long-term effects of a treatment course with oral alendronate of postmenopausal osteoporosis
M. Rossini et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Effects of Denosumab on Bone Mineral Density and Bone Turnover in Postmenopausal Women Transitioning From Alendronate Therapy
David L. Kendler et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus
M. Saito et al.
OSTEOPOROSIS INTERNATIONAL (2010)
Diabetic Patients Have an Increased Risk of Vertebral Fractures Independent of BMD or Diabetic Complications
Masahiro Yamamoto et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Fracture risk in type 2 diabetes: Update of a population-based study
L. Joseph I. I. I. I. Melton et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
Bisphosphonates alter trabecular bone collagen cross-linking and isomerization in beagle dog vertebra
M. R. Allen et al.
OSTEOPOROSIS INTERNATIONAL (2008)
Influence of type 2 diabetes mellitus on bone mineral density response to bisphosphonates in late postmenopausal osteoporosis
Selculk Dagdelen et al.
ADVANCES IN THERAPY (2007)
Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes - a meta-analysis
P. Vestergaard
OSTEOPOROSIS INTERNATIONAL (2007)
Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture
Mohsen Janghorbani et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)
Degree of mineralization-related collagen crosslinking in the femoral neck cancellous bone in cases of hip fracture and controls
Mitsuru Saito et al.
CALCIFIED TISSUE INTERNATIONAL (2006)
How useful are measures of BMD and bone turnover?
PD Miller et al.
CURRENT MEDICAL RESEARCH AND OPINION (2005)
Comparison of bone and total alkaline phosphatase and bone mineral density in postmenopausal osteoporotic women treated with alendronate
NB Watts et al.
OSTEOPOROSIS INTERNATIONAL (2001)
分享论文
